CN220193829U - Health care device - Google Patents
Health care device Download PDFInfo
- Publication number
- CN220193829U CN220193829U CN202320828367.7U CN202320828367U CN220193829U CN 220193829 U CN220193829 U CN 220193829U CN 202320828367 U CN202320828367 U CN 202320828367U CN 220193829 U CN220193829 U CN 220193829U
- Authority
- CN
- China
- Prior art keywords
- low
- frequency wave
- health care
- essential oil
- frequency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036541 health Effects 0.000 title claims abstract description 67
- 239000000341 volatile oil Substances 0.000 claims abstract description 57
- 239000002156 adsorbate Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 description 46
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 25
- 229950006238 nadide Drugs 0.000 description 25
- 210000001744 T-lymphocyte Anatomy 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 16
- 239000012528 membrane Substances 0.000 description 15
- 230000008859 change Effects 0.000 description 13
- 210000000822 natural killer cell Anatomy 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 11
- 238000001467 acupuncture Methods 0.000 description 11
- 210000000170 cell membrane Anatomy 0.000 description 11
- 230000002102 hyperpolarization Effects 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 210000000056 organ Anatomy 0.000 description 11
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 230000036390 resting membrane potential Effects 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 210000003719 b-lymphocyte Anatomy 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 230000036982 action potential Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 102000055501 telomere Human genes 0.000 description 6
- 108091035539 telomere Proteins 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 150000003904 phospholipids Chemical class 0.000 description 5
- 210000003411 telomere Anatomy 0.000 description 5
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 4
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 4
- 238000010241 blood sampling Methods 0.000 description 4
- 239000003990 capacitor Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 3
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002336 repolarization Effects 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 2
- 102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 241000949456 Zanthoxylum Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000010648 geranium oil Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 210000003715 limbic system Anatomy 0.000 description 2
- 230000008376 long-term health Effects 0.000 description 2
- 238000010339 medical test Methods 0.000 description 2
- 230000028161 membrane depolarization Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 210000000196 olfactory nerve Anatomy 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 235000007650 Aralia spinosa Nutrition 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 244000119308 Coleus amboinicus Species 0.000 description 1
- 235000004094 Coleus amboinicus Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000270673 Pelargonium graveolens Species 0.000 description 1
- 235000017927 Pelargonium graveolens Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000010684 cajeput oil Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003738 lymphoid progenitor cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 208000011317 telomere syndrome Diseases 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Massaging Devices (AREA)
- Percussion Or Vibration Massage (AREA)
Abstract
The utility model provides a health care device. The health care device at least comprises a low-frequency wave emitter, a plant essential oil carrier and a low-frequency wave guide body, wherein the plant essential oil carrier is arranged between the low-frequency wave emitter and the low-frequency wave guide body; wherein the low frequency wave transmitter is capable of transmitting a pre-radiationThe low-frequency wave with fixed frequency penetrates through the plant essential oil carrier, then is transmitted to the low-frequency wave guide body, and then the energy of the low-frequency wave is concentrated on the low-frequency wave guide body and is discharged. The health care method is to emit the low-frequency wave with the preset frequency towards the navel of the user by the health care device. The health care device and the health care method can increase NAD in blood + The content of the medicine can be conveniently operated, the using position can be accurately identified, and the non-invasive and non-contact health care effects can be achieved.
Description
Technical Field
The present utility model relates to a health care device, and more particularly to a health care device for transmitting low frequency waves to a human body after passing through a plant essential oil carrier to perform human body health care.
Background
The known health care modes at present include scraping, cupping, acupuncture, massaging and the like, and the health care purposes can be achieved, but the known health care modes also have the defects such as: scraping can cause damage to the skin, increasing the risk of infection; the cupping effect is close to scraping, but the use needs to be contacted with the skin by the cup body, so the cleaning and sanitation of the cup body are considered; acupuncture, in which needles invade acupoints corresponding to the human body, thus having invasive risks; massage, while not risking invasiveness, relies on others to help relax muscles.
The improvement of the above mentioned health care method includes the non-invasive radiation health care device for human body acupoints, such as microwave acupuncture instrument, which uses microwave oscillator with oscillation frequency as high as 1000-2000 megahertz (MHz), which is easy to damage due to excessive radiation (energy). The microwave acupuncture instrument is also a health care device which can not be generalized because the microwave acupuncture instrument is required to correspond to the acupoints of a human body to exert efficacy, but a general person is not a professional related to traditional Chinese medicine and cannot accurately identify the respective acupoints of each person.
Therefore, development of a health care device and a health care method which can be conveniently operated, accurately identify a use position, are non-invasive, non-contact and free from damage caused by excessive energy risk is a trend in the industry.
Disclosure of Invention
The utility model is mainly based on the recognition that the main tissue and organ of the human body (referring to organism, not artificial tissue or organ) has an inherent oscillation frequency, for example, the head is 8-12Hz, the chest is 4-6Hz, the heart is 5Hz, the abdominal cavity is 6-9Hz, the blood flow frequency is 1.2Hz, and the bone tissue is 1.8Hz. When a certain part of the human body is in a low-frequency wave field of 0-20Hz, such as low-frequency electromagnetic waves, such as low-frequency waves or ultrasonic waves (ultrasonic waves or ultrasonic waves which are relatively called above 20 kHz), if the sound pressure intensity (Sound Pressure Level, in dB) reaches a certain threshold value, the elastic wall on the outer layer of the tissue organ corresponding to the part is first brought into a vibrating state, and then the vibration is conducted to the inside of the tissue organ. In particular, resonance occurs when the frequency of the bass wave is synchronized with the aforementioned natural oscillation frequency of the tissue organ, at which time the tissue organ is subjected to the greatest stimulus. When acting on a tissue organ in a resonance mode induced by bass waves, it acts on the cellular structure of the tissue organ, such as the granuloma (mitochondron) of the cell, which is the main site for oxidative phosphorylation in the cell and synthesis of Adenosine Triphosphate (ATP), providing chemical energy for the cell's activity, so there is a "cell power station" (the powerhouse of the cell).
ATP refers to the membrane potential (membrane potential, transmembrane potential or membrane voltage) of the cell membrane, which is a membrane composed of a phospholipid bilayer (phospholipid bilayer), and almost all cell membranes of cellular organisms are mainly composed of a phospholipid bilayer, the inside of which is filled with a dielectric, so that the cell membrane composed of a phospholipid bilayer is equivalent to a capacitor in electrical properties. Not only phospholipid bilayer but also proteins in the structure of the cell membrane, some of which act as ion channels to allow ions (e.g. positively charged sodium ions Na + Potassium ion K + ) Transport across the cell membrane may be performed. This phenomenon can be understood by physics, that is, the cell membrane is a capacitor with electrical leakage, which is the passage of electrical leakage current (ion transport) through the capacitor.
The resonance effect induced by the aforementioned bass wave also affects the adenylate-activating protease (Adenosine monophosphate-activated protein kinase, AMPK for short), for the relation of Low frequency vibrations to AMPK, see "Low-frequency vibration promotes AMPK-mediated glucose uptake in 3T3-L1 adipocs, D.Haba et al., volume7, issue 9, september 2021". Activated AMPK causes an increase in nicotinamide ribosyl phosphate transferase (Nicotinamide phosphoribosyltransferase, NAMPT) and thus nicotinamide adenine dinucleotide (nicotinamide adenine dinucleotide, NAD) + ) The above-mentioned associations can be improved by reference to "AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle, J. Brandauer et al, J physiol.2013oct 15;591 (Pt 20): 5207-5220). Furthermore, due to NAD + Is one of the keys for synthesizing ATP, thus once NAD + An increase in the amount of (a) will also contribute to an increase in the amount of ATP.
In addition, resonance induced by the aforementioned bass wave acts on the granulosa body to affect the binding state of some enzymes such as ATP hydrolase (ATPase) to the cell membrane and the activity of the enzymes. ATPase is an enzyme that breaks down ATP to produce energy and activates Na + K is as follows + Therefore also referred to as Na + -K + ATPase or Na + -K + Pump (Na) + -K + pump)，Na + -K + The pump regulates the concentration of sodium and potassium ions within and outside the cell membrane such that the membrane potential is regulated, for example, by returning to a resting membrane potential (resting membrane potential) from an action potential. First, the cell membrane is at a resting membrane potential, and then the action potential generated by appropriate stimulation of the cell membrane in a resting membrane potential state is typically sequentially subjected to the following phases: polarization (depolarization), depolarization (repolarization), repolarization (repolarization), hyperpolarization (hyperpolarization), in particular when the action potential during the hyperpolarization phase has a membrane potential lower than the resting membrane potential, where Na must be relied on + -K + The pump assists the action potential membrane potential to return to the resting membrane potential during the hyperpolarization phase. Thus, it will be appreciated that the subject is chronically under irritation (e.g., stress) or chronic inflammatory conditions of the human body, orThe long-term lack of ATP and/or ATPase will result in cells that are in the hyperpolarization stage for a long period of time such that the membrane potential will be lower than the resting membrane potential.
Based on the understanding that the cell membrane is electrically equivalent to a capacitor (or a battery), the membrane potential corresponds to the voltage of the battery, and the membrane potential of the action potential in the hyperpolarization stage is lower than the rest membrane potential, wherein the membrane potential of the action potential in the hyperpolarization stage can be understood as the residual electric quantity (voltage) of the battery after the electric quantity is already consumed after the battery is used, and the rest membrane potential can be correspondingly the initial electric quantity (voltage) of the electric quantity which is not consumed or is refilled. It was counted that there were 37.2 megacells on average in humans, that is, 37.2 megacells on average in humans. It will be appreciated that when the body is under stress or inflamed for an extended period of time, the cells are correspondingly in a "battery power depleted" state in the hyperpolarized stage for an extended period of time, so that the cells are unable to perform or maintain their intended function, and the human tissue and organ thus exhibit pathological or tired phenomena. However, at this time, if a low frequency wave of a certain intensity and/or frequency is applied to the cells, the energy of the wave may be converted into heat energy, biochemical energy and bioelectric energy to increase the activity of ATPase, thereby affecting the return of the membrane potential of ATPase to the resting membrane potential in the hyperpolarization stage, which causes the return to the initial charge (voltage) of the full charge of the resting membrane potential corresponding to the aforementioned "battery" of human cells from the aforementioned "battery charge depleted" state of the membrane potential in the aforementioned hyperpolarization stage. In other words, the low frequency wave can "charge" the cells in the hyperpolarization stage, so that the damaged tissue can be repaired under the stimulation of the low frequency wave by acting on the tissue organ. One example of a relationship between low frequency waves and organisms is that the frequency of the schumann resonance (Schumann Resonance) in very low frequency (Extremely Low Frequency, ELF) in low frequency waves is 7.83 Hz, which is just the same as the frequency of the hippocampus of the brain of a mammal, particularly the alpha and theta waves of the brain of a human being are also approximately 8Hz, so that the National Aviation and Space Agency (NASA) installs a schumann wave generator in a manned space capsule to maintain the space staff in the spaceThe body and mind in the air are healthy. For an increase in ATPase activity by low frequency waves, see "Effects of low frequency magnetic fields on Na, K-ATPase activity, M.Blank, L.Soo, V.Papstein, bioelectrochemistry and Bioenergetics 38 (1995) 267-273", wherein low frequency waves (magnetic waves) of 0-70Hz are employed to cause Na + -K + The activity of ATPase is increased by 5-10%. In other words, the low frequency wave may "charge" the cells in the hyperpolarization stage by activating the cells, and thus the low frequency wave may be applied to "cell activation technology". In particular, the low-frequency wave may include an electromagnetic wave such as an electric wave, a magnetic wave, or an optical wave, or a bass wave.
Thus, it was found that the above bass wave causes an increase in the amount and/or activity of ATP and/or ATPase. Next, since ATPase hydrolyzes (hydrolyses) ATP and generates energy, helicase (helicases) can use the energy generated by these hydrolyses to unwind (unwind) DNA (the double helix structure of the DNA) the double helix of DNA from double helix (double helix) of deoxyribonucleic acid (deoxyribonucleic acid, abbreviated as DNA) to facilitate DNA Polymerase (DNA Polymerase) for smooth DNA replication and repair of damaged genes (genes) in addition to cell division.
In addition, the utility model recognizes that according to the theory of traditional Chinese medicine, the navel of a human body is the Shenque point and is the place where the conception vessel, the governor vessel, the belt vessel and the pulse pass, so that when the Shenque point is stimulated, the whole body can be regulated by connecting the meridians with the viscera and six fu organs. Furthermore, according to the theory of Western medicine, the navel is the thinnest part of the epidermal horny layer in the abdomen of the human body and has no adipose tissue under the navel, so the barrier function is the weakest. In addition, since navel skin has a rich venous network and branches of the abdominal artery in addition to the microcirculation blood vessels of general skin, it is possible to bring the effect or change into the blood circulation system of the human body by only performing a certain effect or change on blood in the microcirculation blood vessels of navel skin. Moreover, the navel of the human body can be easily identified, and the position of the navel can not be different according to the body height, fat and thin of the human body, so that the navel is used as a health care device to be applied to the corresponding position of the human body, and the navel has the advantage that a user can accurately identify the using position.
The utility model recognizes that the low-frequency wave emitter capable of generating low-frequency waves (such as low-frequency electric waves, low-frequency magnetic waves and low-frequency sound waves) can emit the low-frequency waves towards the navel in a way of not contacting with the navel so as to achieve the effect similar to acupuncture, thereby achieving a non-invasive and non-contact health care way. Preferably, the bass wave emitter capable of generating bass waves is used for emitting the bass waves towards the navel in a mode of not contacting with the navel so as to achieve the effect similar to acupuncture, thus a non-invasive and non-contact health care mode can be achieved, and particularly, the bass waves, the low-frequency sound waves and the low-frequency sound waves refer to the same meaning. If the bass wave is directly used as a component of the health care device, the problem of damage caused by excessive energy risk generated by the high-frequency microwave oscillator can be avoided, and meanwhile, adverse effects of electric waves or magnetic waves on people with special physique can be avoided. Therefore, the effect similar to acupuncture achieved by the present utility model described above may also be referred to as "qi moxibustion".
Since the effect similar to acupuncture can be achieved by recognizing bass waves (gas moxibustion), and the influence of acupuncture on the immune system is that acupuncture can increase the content of Interferon gamma (gamma-IFN) and neuropeptide beta-endorphin (beta-enkephalin) to activate NK cells (natural killer cell), the NK cells also secrete cytokines (cytokine) which can regulate inflammatory response. NK cells, which are immune cells and are formed by the development of bone marrow lymphoid stem cells, are large-grained lymphocytes in the cytoplasm, and are mainly distributed in peripheral blood (including blood in microcirculation) and spleen, and are also present in small amounts in lymph nodes and other tissues.
The barrier function is the weakest because the navel is the thinnest part of the epidermal horny layer in the human abdomen and there is no adipose tissue under the navel. In addition, navel skin has abundant venous network and abdominal artery branches in addition to general skin having microcirculation blood vessels, so that it can be brought into the blood circulation system of human body by performing a certain action or change on blood in the navel skin microcirculation blood vessels, therefore, when bass waves are emitted toward navel by a bass wave emitter, acupuncture-like effect is induced, so that the content of gamma-IFN and beta-enkephalin in the navel skin microcirculation blood vessels is increased to activate NK cells, B cells (B cells, B lymphote) and activated T cells (Active T cells, active T lymphocyte), and inflammatory reaction or secretion of antibodies can be regulated because NK cells, B cells and activated T cells secrete cell hormones. The method of increasing the content of enkephalin may be that the above-mentioned bass wave is applied to a container containing essential oil (essential oil) to agitate the essential oil in the container (refer to US6063894a or EP3970507 A1), so that the essential oil taste molecules are accelerated to leave the container and are transferred to the olfactory nerve and are transferred to the cerebral limbic system, thereby increasing the amount of secreted enkephalin to activate NK cells, B cells and activated T cells. Furthermore, essential oils are synthesized by photosynthesis of cells near the glands of plants, so that most of the leaves of plants contain essential oils, or essential oils produced in the leaves penetrate the cell walls into the glands and are stored in other parts of the plants. Thus, the aforementioned bass wave acting on plants also dissipates the essential oils stored in the plants into the air (see US3491022a for the influence of bass waves on reverse osmosis) and is transmitted to the olfactory nerve and to the limbic system of the brain, thus increasing the amount of secreted enkephaline and activating NK cells, B cells and activated T cells. The aforementioned bass wave also has the effect of unwinding the double helix structure of DNA when applied to leaves and other parts of plants containing sufficient water.
In addition, the present utility model recognizes NAD + And/or the essential oils may protect telomeres (telemere), reference may be made to "Effects of Essential Oils on Telomere Length in Human Cells, plant J, plant, med Aromat Plants 2016, 5:2", for association of essential oils with telomeres, for NAD + Association with telomeres can be referred to as "NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction, amanda J Stock andYie Liu,Front Aging.2021；2:785171”。
in addition, when a bass wave is emitted toward the navel with a bass wave emitter, na which activates T cells in blood in the blood vessel of the navel skin microcirculation is also caused + -K + The activity of ATPase is increased, so that the activity of activated T cells can be improved; in other words, when a bass wave is emitted toward the navel with a bass wave emitter, activated T cells having low activity can be "charged" to restore the activity, so that the activated T cells after being "charged" can be re-examined. Therefore, the efficacy of the health care device can be verified by detecting the content change of NK cells, B cells or activated T cells in blood; of course, the ability of NK cell lines to kill cancer tumor cell lines (K562) can also be used, for example, by measuring the ability of NK cells to kill target cells (Effector to target cell ratio, E/T ratio) in a mixed culture sample and comparing the differences in the results to verify the feasibility of the utility model.
In addition, NAD is induced based on the aforementioned bass wave + The increase in ATP and/or ATPase amount and/or activity to allow DNA double helix structure to unwind and facilitate cell division, so long as NAD in blood is detected + The efficacy of the health care device of the utility model can be verified by the content change of NK cells, B cells or activated T cells.
Based on the above description, the present utility model provides a health care device, which at least comprises a low-frequency wave emitter, a plant essential oil carrier and a low-frequency wave guiding body, wherein the plant essential oil carrier is arranged between the low-frequency wave emitter and the low-frequency wave guiding body; the low-frequency wave emitter can emit a low-frequency wave with a preset frequency, and the low-frequency wave firstly penetrates through the plant essential oil carrier, then is transmitted to the low-frequency wave guide body, and then the energy of the low-frequency wave is concentrated on the low-frequency wave guide body and is emitted.
In one embodiment, the plant essential oil carrier contains a plant essential oil.
In one embodiment, the plant essential oil carrier is a part of the plant containing the plant essential oil, or the plant essential oil is loaded in a container, or the plant essential oil is adsorbed on an adsorbate.
In one embodiment, the predetermined frequency is between 1.27 and 1.81 Hz.
In an embodiment, the low-frequency waveguide body comprises a column body and/or a cone body, wherein the column body or the cone body is provided with a containing space, and the plant essential oil carrier is arranged in the containing space.
In one embodiment, the health care device is arranged on a frame body and is positioned in front of a navel of a user to form a preset position with a preset distance from the navel, and the preset distance is between 5 and 8 centimeters.
In one embodiment, the low frequency waveguide is located at the predetermined position.
In one embodiment, the energy of the low frequency wave is concentrated in the low frequency wave guide body and discharged, and then emitted toward the navel to reach the navel.
The health care device and the health care method can achieve the health care effects of being convenient to operate, accurately identifying the using position, being non-invasive, non-contact and not having excessive energy risk to cause injury.
Drawings
FIG. 1 is a schematic diagram of the health care method of the present utility model in practice.
Fig. 2 is a schematic structural view of the health care device for performing the health care method according to the present utility model.
Fig. 3 is a schematic structural view of the health care device of the present utility model.
Fig. 4 is a schematic structural view of the health care device provided with the pipeline according to the present utility model.
Fig. 5 is a schematic structural view of the health care device provided with the upright type stick body of the present utility model.
Fig. 6 is a schematic structural view of the health care device of the present utility model disposed on a frame.
Fig. 7 is a schematic view showing a structure in which a low-frequency wave emitter of the health care device of the present utility model is disposed on the bottom surface of a cone.
Description of the figure:
1: user' s
11: navel
2: low frequency wave transmitter
21: power supply
22: vibrating piece
200: frame body
100: health care device
3: column body
31: column top surface
32: column bottom surface
33: column body
331: accommodating space
4: cone body
40: vertex point
401: rod body
402: tip of stick body
41: cone bottom surface
42: cone body
5: pipeline
A: plant essential oil carrier
C: center of cone bottom surface
D: predetermined distance
N: cone bottom surface normal
P: predetermined position
S: virtual cone
S1: virtual vertex
S2: virtual bottom surface
W: low frequency waves.
Detailed Description
Referring to fig. 1, in a health care method provided by the present utility model, a low frequency wave W with a predetermined frequency is emitted toward a navel 11 by a low frequency wave emitter 2 at a predetermined position P in front of the navel 11 of a user 1 and forming a predetermined distance D with the navel 11. The front part refers to the front part of the abdomen of the human body and corresponds to the back part of the human body, and the predetermined position P is located on a virtual bottom surface S2 of a virtual cone S with the navel 11 as a virtual vertex S1, so that the predetermined distance D is not more than 8 cm, or not less than 5 cm, or between 5 and 8 cm. Preferably, the predetermined position P is located at the center of the virtual bottom surface S2, for example, the virtual cone S is a cone and the predetermined position P is located at the center of the circular virtual bottom surface S2 and the predetermined distance D is between 5 and 8 cm from the navel 11. A plant essential oil carrier a is disposed between the predetermined position P and the virtual vertex S1, and the plant essential oil carrier a contains a plant essential oil, wherein the plant essential oil refers to an oily substance stored in or obtained from a plant and volatile at room temperature, so that the plant essential oil carrier a may be a part of the plant containing the plant essential oil, such as a root, a stem, a leaf, a flower, a fruit, and a seed, such as a leaf of a left-hand incense (Plectranthus amboinicus), or the plant essential oil carrier a may be obtained by loading various plants into a container through a known distillation method or an extraction method, or may be adsorbed on an adsorbate, such as cotton, paper. The plant essential oil is, for example, tea tree oil, bitter oil, left hand sesame oil, lemon oil, wintergreen oil, camphor tree oil, clove oil, peppermint oil, eucalyptus oil, citronella oil, zanthoxylum oil, sage oil, eucalyptus oil, rose oil, jasmine oil, geranium oil, rose geranium oil, ylang oil, rosemary oil, permanent flower oil, thyme oil, pine oil, cedar oil, juniper oil, sandalwood oil, basil oil, lyme oil, orange oil, sweet orange oil, bitter orange leaf oil, orange flower oil, citrus oil, pricklyash oil, achyranthes oil, cajeput oil or ginger oil. The low-frequency wave W emitted from the low-frequency wave emitter 2 toward the navel 11 penetrates the plant essential oil carrier a before reaching the navel 11.
The low-frequency wave emitter 2 is preferably a low-frequency wave transducer, so the low-frequency wave W may be a low-frequency wave, the low-frequency wave transducer includes a power source 21 and a vibrating member 22, the vibrating member 22 is electrically connected to the power source 21, the vibrating member 22 is a disc-shaped piezoelectric ceramic transducer made of piezoelectric material polarized in a thickness direction, the power source 21 provides power to the vibrating member 22 to vibrate the vibrating member 22 in the thickness direction to generate the low-frequency wave with the predetermined frequency, wherein the predetermined frequency is not more than 1.81Hz, or the predetermined frequency is not less than 1.27Hz, or the predetermined frequency is between 1.27Hz and 1.81 Hz. Optimally, the predetermined frequency is 1.45Hz.
In other words, the present utility model also provides a health care device disposed in front of a navel 11 of a user 1 and forming a predetermined position P of a predetermined distance D from the navel 11, the health care device at least comprising a low frequency wave emitter 2.
< detection method and Effect >
Example 1 in table 1 below is the execution of the foregoing healthcare method for A1 person and A2 person, wherein the predetermined distance D is 5 cm, the predetermined frequency is 1.45Hz, and the low frequency wave is a bass wave. The age of the A1 person is 74 years, male; age of A2 person is 72 years, female. Before the health care method is executed, immunological examination is carried out on the A1 personnel and the A2 personnel for blood sampling and delivery medical examination, and the content percentage of the activated T cells is examined. The A1 person was again subjected to the immunological test for blood sampling and delivery of the medical test at 19 days after 2 hours of the above-mentioned health method, and the A2 person was also subjected to the immunological test for blood sampling and delivery of the medical test at 42 days after 2 hours of the above-mentioned health method, and the percentage of activated T cells was also examined in the same manner, and the results were shown in Table one below. Comparative example 1 in table 1 differs from example 1 in that comparative example 1 did not use the plant essential oil carrier a.
TABLE 1
As can be seen from Table 1, the A1 person had a 206.5% change in the activated T cell content in comparative example 1 where the plant essential oil carrier was not used, and a 234.8% change in the activated T cell content in example 1 where the plant essential oil carrier was used, that is, the aforementioned health method using the plant essential oil carrier could increase the activated T cell content by 28.3%. A2 personnel in "no" using plant essential oil carrier of comparative example 1 with a change rate of 149% of the activated T cell content, in "with" using plant essential oil carrier of example 1 with a change rate of 180% of the activated T cell content, namely with the use of plant essential oil carrier of the aforementioned health care method can make the activated T cell content increase by 31%. Obviously, the health care method of the utility model is deeply effective and can maintain long-term health care efficacy.
< detection method and Effect two >
Examples 2, 3, 4 and 5 in table 2 below are the aforementioned healthcare methods performed on persons A3, A4, A5 and A6, respectively, wherein the predetermined distance D is 5 cm, the predetermined frequency is 1.45Hz, and the low frequency wave is a bass wave. The age of the A3 person is 67 years old men, the age of the A4 person is 64 years old men, the age of the A5 person is 73 years old women, and the age of the A6 person is 47 years old women. Before the health care method is executed, immunological examination is respectively carried out on the A3, A4, A5 and A6 personnel blood sampling and delivery medical examination to examine NAD + The concentration is nanomoles per liter (nmol/L). The immunological tests were again carried out on the A3, A4, A5 and A6 persons, respectively, on the 19 th day after 2 hours of the above-mentioned health method, and NAD was also examined in the same manner + Concentration. The results are shown in Table 2 below.
TABLE 2
As can be seen from Table 2, the NAD of the A3 person before the health care method is performed + Concentration of NAD after the above-mentioned health-care method was carried out at 43nmol/L + The concentration was 116nmol/L and the rate of change was 270%, i.e., NAD + The concentration was increased by 160%. Similarly, the A4 person NAD before performing the aforementioned healthcare method + The concentration was 26nmol/L, NAD after the above-mentioned health method was performed + The concentration was 64nmol/L and the rate of change was 246%, i.e., NAD + Concentration is increased by 146%. NAD of A5 personnel before executing the aforementioned healthcare method + The concentration was 23nmol/L, NAD after the execution of the aforementioned health method + The concentration was 42nmol/L and the rate of change was 183%, i.e., NAD + The concentration was increased by 83%. NAD of A6 personnel before executing the aforementioned health care method + The concentration was 32nmol/L, NAD after the above-mentioned health method was performed + The concentration was 53nmol/L and the rate of change was 166%, i.e., NAD + The concentration was increased by 66%. Therefore, the health care method provided by the utility model can promote NAD + Concentration proliferation and NAD can be obtained by performing for 2 hours only once + The concentration is increased, and obviously, the health care method of the utility model is deep and effective and can maintain long-term health care efficacy.
Referring to fig. 2 and 3, the present utility model further provides a health care device 100 for performing the health care method, wherein the health care device 100 comprises the low frequency wave emitter 2, a cylinder 3 and a cone 4. The column 3 is preferably a cylinder, and has a top surface 31, a bottom surface 32, and a shaft 33 with two ends connected to the top surface 31 and the bottom surface 32, respectively, wherein the shaft 33 is provided with a receiving space 331 recessed from the bottom surface 32 toward the top surface 31, and the plant essential oil carrier a is disposed in the receiving space 331. The cone 4 has a vertex 40, a cone bottom 41 and a cone 42 with two ends connected to the vertex 40 and the cone bottom 41, respectively. Wherein the cylindrical top surface 31 is correspondingly engaged with the conical bottom surface 41, for example, by welding or screw locking. Preferably, the column 3 and the cone 4 are respectively a metal column and a metal cone. More preferably, the pillar 3 and the cone 4 are integrally formed, in other words, the pillar top 31, the pillar body 33, the cone 42 and the apex 40 are integrally formed. Specifically, the combination of the pillar 3 and the taper 4 is called a low-frequency waveguide.
The low frequency wave emitter 2 is connected to the bottom surface 32 of the column, preferably the low frequency wave emitter 2 is directly connected to the bottom surface 32 of the column, for example, the low frequency wave emitter 2 is welded or screwed to the bottom surface 32 of the column, so that the vibration member 22 generates the low frequency wave W of the predetermined frequency when the power source 21 is activated (refer to fig. 1 again). Then, the low frequency wave W is transmitted to the column bottom 32 and penetrates the plant essential oil carrier a, and then is transmitted to the cone bottom 41 and the vertex 40 of the cone 4 by the column shaft 33 in sequence, and is formed into a cone shape by the wider cone bottom 41 and the narrower cone bottom 40 of the cone 4, so that the energy of the low frequency wave W is concentrated as it is transmitted to the vertex 40. Therefore, when the low frequency wave W is transmitted to the vertex 40, the energy thereof is concentrated to the maximum and emitted from the vertex 40 toward the navel 11; since the apex 40 of the cone 4 is a tip, the low frequency wave W can form a principle similar to "tip discharge" in electricity to concentrate the energy of the low frequency wave W to the apex 40 and emit toward the navel 11 to reach the navel 11. Specifically, the vertex 40 is located at the predetermined position P.
Referring to fig. 4, in another embodiment, the low frequency wave emitter 2 is connected to the column bottom 32 and the accommodating space 331 through a pipe 5, and the low frequency wave W is transmitted from the low frequency wave emitter 2 to the column bottom 32 and the accommodating space 331 through the pipe 5, then transmitted to the vertex 40 after penetrating the plant essential oil carrier a as described above, and emitted toward the navel 11 to reach the navel 11. The power source 21 and/or the vibrating member 22 of the low frequency wave transmitter 2 can be far away from the human body by the arrangement of the pipeline 5, so as to avoid the interference of the electronic device implanted in the human body.
Referring to fig. 5, in another embodiment, a vertical rod 401 is further disposed at the vertex 40 in a direction away from the cone bottom 41, preferably the rod 401 is a metal rod such as a wire or a wire, and the length direction of the rod 401 coincides with the cone bottom normal N passing through the cone bottom center C of the cone bottom 41 and faces the navel 11. Accordingly, the energy of the low frequency wave W can be more guided to be concentrated at a rod tip 402 of the rod 401 to be discharged and emitted toward the navel 11. Specifically, the tip 402 of the wand is now positioned at the predetermined position P.
Referring to fig. 6, in another embodiment, the health care device 100 is disposed on a stand 200, the user 1 is lying on a platform (not shown), the stand 200 is mounted on the platform, and the health care device 100 is located above the navel of the user. In this way, the user can also get a proper rest during the healthcare process.
Referring to fig. 7, in another embodiment, the health care device 100 may also include the low frequency wave emitter 2 and the cone 4, but not include the column 3, wherein the cone 42 is provided with the accommodating space 331 recessed from the cone bottom surface 41 toward the vertex 40, and the plant essential oil carrier a is disposed in the accommodating space 331. Specifically, the cone 4 is the low frequency waveguide, and does not include the column 3. The low-frequency wave emitter 2 is disposed on the cone bottom surface 41, the low-frequency wave emitter 2 is connected to the cone bottom surface 41, preferably the low-frequency wave emitter 2 is directly connected to the cone bottom surface 41, for example, the low-frequency wave emitter 2 is adhered, welded or screwed to the cone bottom surface 41, so that the vibration member 22 generates the low-frequency wave W with the predetermined frequency after the power source 21 is started (refer to fig. 1 again). Then, the low-frequency wave W is transmitted to the cone bottom surface 41 of the cone 4 and penetrates the plant essential oil carrier a, and then is transmitted to the vertex 40, and the cone 4 is formed into a cone shape from the wider cone bottom surface 41 to the narrower cone bottom surface 40, so that the energy of the low-frequency wave W is concentrated as it is transmitted to the vertex 40. Preferably, the cone 4 is an integrally formed wooden cone.
Claims (8)
1. The health care device is characterized by at least comprising a low-frequency wave emitter (2), a plant essential oil carrier (A) and a low-frequency wave guide body, wherein the plant essential oil carrier (A) is arranged between the low-frequency wave emitter (2) and the low-frequency wave guide body; the low-frequency wave emitter (2) can emit a low-frequency wave (W) with a preset frequency, and the low-frequency wave (W) firstly penetrates through the plant essential oil carrier (A), then is transmitted to the low-frequency wave guide body, and then the energy of the low-frequency wave (W) is concentrated on the low-frequency wave guide body and is emitted.
2. The health care device as claimed in claim 1, wherein the plant essential oil carrier (a) contains a plant essential oil.
3. The device according to claim 2, wherein the plant essential oil carrier (a) is a part of the plant containing the plant essential oil, or the plant essential oil is loaded in a container, or the plant essential oil is adsorbed on an adsorbate.
4. A health care device according to claim 3, characterized in that the predetermined frequency is between 1.27 and 1.81 Hz.
5. The device according to claim 4, wherein the low frequency wave guide body comprises a column (3) and/or a cone (4), the column (3) or the cone (4) is provided with a containing space (331), and the plant essential oil carrier (a) is disposed inside the containing space (331).
6. The device according to claim 5, wherein the device (100) is disposed in a frame (200) and is located in front of a navel (11) of a user (1) to form a predetermined position (P) of a predetermined distance (D) from the navel (11), the predetermined distance (D) being between 5 and 8 cm.
7. The healthcare device according to claim 6, wherein the low frequency waveguide is located at the predetermined position (P).
8. The apparatus according to claim 7, wherein the energy of the low frequency wave (W) is concentrated in the low frequency wave guide body and discharged, and then emitted toward the navel (11) to reach the navel (11).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW112203278 | 2023-04-11 | ||
| TW112203278U TWM643521U (en) | 2023-04-11 | 2023-04-11 | health care device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN220193829U true CN220193829U (en) | 2023-12-19 |
Family
ID=88148280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202320828367.7U Active CN220193829U (en) | 2023-04-11 | 2023-04-14 | Health care device |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN220193829U (en) |
| TW (1) | TWM643521U (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI832746B (en) * | 2023-04-11 | 2024-02-11 | 李洲科技股份有限公司 | health device |
-
2023
- 2023-04-11 TW TW112203278U patent/TWM643521U/en unknown
- 2023-04-14 CN CN202320828367.7U patent/CN220193829U/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TWM643521U (en) | 2023-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10960206B2 (en) | Bioelectric stimulator | |
| CN1980610B (en) | Electromagnetic treatment apparatus | |
| CN101443074A (en) | Integrated coil device and method for using the same | |
| CN220193829U (en) | Health care device | |
| US20100099942A1 (en) | Method and apparatus for electromagnetic human and animal immune stimulation and/or repair systems activation | |
| US20130218235A9 (en) | Excessive fibrous capsule formation and capsular contracture apparatus and method for using same | |
| CN204995996U (en) | Height dual -frenquency supersound electric conductance therapeutic instrument | |
| Omura | Basic electrical parameters for safe and effective electro-therapeutics [electro-acupuncture, TES, TENMS (or TEMS), TENS and electro-magnetic field stimulation with or without drug field] for pain, neuromuscular skeletal problems, and circulatory disturbances | |
| CN217661124U (en) | Health care device | |
| EP3579916B1 (en) | Device for intracellular transport in resonance | |
| TWM638574U (en) | Healthcare apparatus | |
| RU2244573C2 (en) | Method for applying cosmetic/medical therapy | |
| CN118787865A (en) | Health care device and health care method | |
| US20160339261A1 (en) | Medical Bioelectric Plasma Beam | |
| CN219049394U (en) | Health care device | |
| CN117919072A (en) | Health care device and health care method | |
| KR20240151630A (en) | Health care device and health care method | |
| US20240115457A1 (en) | Health care device and health care method | |
| WO2015041254A1 (en) | Device for treating vascular endothelial dysfunction, method for treating vascular endothelial dysfunction, and activation control method for plcγ1, erk5 or erk1/2 | |
| Omura | Treatment of acute or chronic, severe, intractable pain and other intractable medical problems associated with unrecognized viral or bacterial infection: Part I | |
| US20150273221A1 (en) | Method and apparatus for inducing endogenous generation of adult stem cells | |
| CN116920281A (en) | Health care device and health care method | |
| Wisneski et al. | Energy Medicine: Focus on Nonthermal Electromagnetic Therapies | |
| Turrell | The principles of electrotherapy and their practical application | |
| BR102021025658A2 (en) | KLOTHO MODULATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |